Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for aGVHD prevention in SCID infants
NCT02177760Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jul 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in Acute Graft-Versus-Host Disease (aGvHD), sponsored by University of California, San Francisco. Planned start Jul 2014; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02177760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177760.